Results 31 to 40 of about 1,257,507 (228)

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

open access: yesPharmaceuticals, 2010
Cannabis contains the psychoactive component delta9-tetrahydrocannabinol (delta9-THC), and the non-psychoactive components cannabidiol (CBD), cannabinol, and cannabigerol.
Michihiro Fujiwara   +2 more
doaj   +1 more source

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

open access: yesNeurobiology of Disease, 2005
We have observed that systemic administration of cannabinoid CB1 antagonists exerts antiparkinsonian effects in rats with very severe nigral lesion (>95% cell loss), but not in rats with less severe lesion (85–95% cell loss).
Emilio Fernandez-Espejo   +6 more
doaj   +1 more source

Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. [PDF]

open access: yesPLoS ONE, 2011
Well balanced novelty seeking and exploration are fundamental behaviours for survival and are found to be dysfunctional in several psychiatric disorders.
Martin Häring   +3 more
doaj   +1 more source

Cardiorespiratory anomalies in mice lacking CB1 cannabinoid receptors. [PDF]

open access: yesPLoS ONE, 2014
Cannabinoid type 1 (CB1) receptors are expressed in the nervous and cardiovascular systems. In mice, CB1 receptor deficiency protects from metabolic consequences of a high-fat diet (HFD), increases sympathetic activity to brown fat, and entails sleep ...
Alessandro Silvani   +8 more
doaj   +1 more source

Signal transduction of the CB1 cannabinoid receptor [PDF]

open access: yesJournal of Molecular Endocrinology, 2009
The CB 1 cannabinoid receptor (CB 1 R) is the major cannabinoid receptor in neuronal cells and the brain, but it also occurs in endocrine cells and other peripheral tissues.
Gábor, Turu, László, Hunyady
openaire   +2 more sources

CB1 cannabinoid receptor expression in the striatum: Association with corticostriatal circuits and developmental regulation

open access: yesFrontiers in Pharmacology, 2012
Corticostriatal circuits mediate various aspects of goal-directed behavior and are critically important for basal ganglia-related disorders. Activity in these circuits is regulated by the endocannabinoid system via stimulation of CB1 cannabinoid ...
Vincent eVan Waes   +4 more
doaj   +1 more source

The role of cannabinoid CB1 receptors in the antinociceptive and reparative actions of mesenchymal stem cells in rats with peripheral neuropathic pain

open access: yesIbrain, 2023
Mesenchymal stem cells (MSCs) can produce antinociceptive and reparative effects. Presumably, the MSCs‐induced antinociception may be partly due to the involvement of the endocannabinoid system.
Anna‐Maria V. Yerofeyeva   +3 more
doaj   +1 more source

Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray

open access: yesPAIN Reports, 2021
. Introduction:. The periaqueductal gray (PAG) mediates the antinociceptive properties of analgesics, including opioids and cannabinoids. Administration of either opioids or cannabinoids into the PAG induces antinociception.
Adrianne R. Wilson-Poe   +7 more
doaj   +1 more source

Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability

open access: yesFrontiers in Behavioral Neuroscience, 2015
The endocannabinoid system possesses neuromodulatory functions by influencing the release of various neurotransmitters, including γ-aminobutyric acid (GABA) and glutamate.
Beat eLutz   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy